+390677209020 | +39 0267380552 info@direnzo.biz | sedemilano@direnzo.biz | Italian Language

Serialization of Italian Drugs: What changed?

Serialization for drug traceability

With the Legislative Decree no. 10 of 6 February 2025 Italy has adopted Directive 2011/62/EU establishing that, as of 9 February 2027 all packs of drugs falling into the field of application of the Falsified Medicines Directive (FMD) shall include a unique identification (Datamatrix).

In the latest months, Implementation Decrees followed one another, in particular the one dated 6 March 2025 on the Datamatrix technical specifications and the one dated 20 May on the Special Paper Device specifications.

With the Decree of 20 May it was established that the information included in the current antifraud sticker are to be eliminated, in fact the Special Paper Device that will be applied on the packs of medicinal products falling into the field of application of article 2 of the FMD will be considered as a sort of “dumb sticker”, in the sense that it will not include any information as the current sticker does, and will work as an actual authenticity mark.

The use of the current antifraud sticker will continue in the future, and will be applied on the packs of all drugs that do not fall into the field of application of the FMD, in particular on OTCs not subject to medical prescription.

In January 2024 a no-profit consortium-structured company was created – NMVO (National Medicines Verification System) – whose task is to implement and manage the technological network for the authentication of the drugs via the Datamatrix with the corresponding European EMVO (European Medicines Verification System).

All stakeholders of the drug distribution channel (from the packaging site to hospitals and pharmacies) will be equipped with information systems for the commissioning and decommissioning of packs of medicinal products.

After the first pilot project that tested the equipment for the application of the new Special Paper Device on the packs of medicines not intended for market distribution, a second pilot project was recently launched aiming at testing all operating and information systems connecting the national body (NMVS) and the European one (EMVS) as well as the information systems integrated with the TS system (Italian health insurance card) supplied to pharmacies. It is an actual end-to-end control with the packs of medicines intended for the retail channel.

The most critical point of the Datamatrix application regarded a further piece of information to be included along with that provided for and implemented in other European countries: the one concerning the MA number.

This criticality was overcome by adding a fifth line. Therefore, along with the four lines already expected and used in the other European countries, reporting the Product Code, Serial Number, batch number and expiry date, in Italy there will be a fifth line for the MA code.

Drug traceability and role of IPZS

Legislative Decree no. 10 of 6 February 2025 provides for a transition period up to 8 February 2027 during which the current antifraud stickers can be still used. Moreover, all batches released within this date, on which the current antifraud stickers were applied, can be marketed until the batch expiry date.

The packs of drugs with “old” antifraud stickers will still be subject to the traceability data transmission as provided for by Legislative Decree 540 of 30 December 1992, in particular those concerning production during the phase of application of the stickers on the packs.

However, the obligation of traceability data transmission (except for the SFR flow) still applies for all packs of drugs intended for public facilities, as provided for by the same Decree.

The most recent issue of the Decree of 16 June 2026 concerns the monitoring of the packs within the Italian distribution channel via the central database managed by the Ministry of Health.

This has replaced the Decree of 15 July 2004 instituting a central database at the Italian Medicine Agency finalized to the monitoring of packs of medicines within the Italian distribution system.

With the new decree, this database has evolved and has become interoperable with the European central network.

Special interest is reserved to medicines falling into the field of application of article 2 of the European Directive 2016/161 then adopted with Decree no. 10 of 6 February 2025.

The Directive also outlines the new role of the Italian State Mint and Security Printer IPZS within the NMVO as manager of the national archive, and defines the obligations of the stakeholders that shall feed the central database. However, the IPZS will still manufacture the current antifraud stickers for the drugs not falling into the field of application of Decree no. 10 of 6 February 2025, as well as the new Special Paper Device, for those drugs falling into the field of application of the FMD.

Written on 21/09/2026 by Carmine Spina